BeyondSpring, Inc. - Ordinary Shares (BYSI): Price and Financial Metrics
BYSI Price/Volume Stats
| Current price | $1.60 | 52-week high | $3.75 |
| Prev. close | $1.67 | 52-week low | $1.43 |
| Day low | $1.60 | Volume | 3,645 |
| Day high | $1.66 | Avg. volume | 12,430 |
| 50-day MA | $1.71 | Dividend yield | N/A |
| 200-day MA | $1.98 | Market Cap | 62.45M |
BYSI Stock Price Chart Interactive Chart >
BeyondSpring, Inc. - Ordinary Shares (BYSI) Company Bio
BeyondSpring is a global clinical stage biopharmaceutical company developing innovative immuno-oncology cancer therapies. The co is advancing its lead asset, Plinabulin, into a Phase 3 clinical trial as a direct anticancer agent in non-small cell lung cancer and a Phase 2/3 clinical trial in the prevention of chemotherapy-induced Neutropenia.
BYSI Price Returns
| 1-mo | -6.43% |
| 3-mo | 0.63% |
| 6-mo | -24.88% |
| 1-year | -46.31% |
| 3-year | -31.33% |
| 5-year | -88.71% |
| YTD | -1.84% |
| 2024 | 81.11% |
| 2023 | -52.13% |
| 2022 | -58.50% |
| 2021 | -62.87% |
| 2020 | -21.29% |
Loading social stream, please wait...